Your Article Summary
Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
BayNews International, 09/18/09
Bayer Schering Pharma announced that data from more than 30 clinical trials evaluating three products in the company’s oncology portfolio – Nexavar tablets, regorafenib and Alpharadin™ – will be presented at the joint 15th European CanCer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress, September 2009 in Berlin, Germany.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09
User Groups Prove Helpful
HealthDataManagement, 11/03/09
Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09
Article Search
Sponsor


See Latest Articles


